Alguns aspectos sobre geradores e radiofármacos de tecnécio-99m e seus controles de qualidade

Radiologia Brasileira 01/2001; 34. DOI: 10.1590/S0100-39842001000400011
Source: DOAJ


Radiofármacos marcados com tecnécio-99m são os principais agentes para diagnósticos utilizados nas clínicas de medicina nuclear, em função de uma série de características físicas do radionuclídeo e pela praticidade dos radiofármacos serem preparados no local de uso, por meio de uma reação de complexação entre um agente complexante (fármaco) e o tecnécio-99m. Entretanto, durante esta reação podem ser geradas algumas impurezas que proporcionam a formação de produtos com baixa qualidade ou com características diferentes das desejadas. No presente trabalho serão apresentados alguns dos fatores que podem interferir na qualidade dos radiofármacos e os controles que podem ser utilizados para garantir sua qualidade.

Download full-text


Available from: Carlos Buchpiguel,
409 Reads
    • "Some studies[46] of splenic nodules self-implantation into the major omentum has been done using sulfur colloid labeled (splenosis) with technetium-99; however, in this series of late followup tin was used. This mineral has good specificity for marking the reticuloendothelial system, where quality control is done properly.[17] In this sense, nuclear medicine was of greater accuracy and specificity for mapping of the remaining splenic nodules after an average followup of more than 10 years. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In children suffering from severe hepatosplenic schistosomiasis, the surgical protocol includes splenectomy and autoimplantation of spleen morsels in the major omentum, which has the potential of reducing the overwhelming postsplenectomy infection (OPSI). The purpose of the study was to evaluate the remaining splenosis, with the mean postoperative followup of 12.1 ± 5.6 years; to compare the efficacy of the 2 evaluation tools. Nineteen patients underwent, when they were children, portal decompression and autoimplantation of spleen. After a mean age of 23.4 ± 5.3 years, they were investigated regarding the number of infections and OPSI. They had undergone hepatosplenic scintigraphy with labeled colloidal SnTc(99m) and abdominal ultrasound. It was considered efficient splenosis when the patients presented with 5 or more spleen nodules. The evaluation was performed by 3 observers. None of the patients had increased infection rate or developed OPSI. Sixteen (84.2%) presented efficient splenosis. The remaining postoperative splenosis was considered efficient in the majority of patients in the long-term followup; and nuclear medicine was considered the gold standard for splenosis evaluation.
    Journal of Indian Association of Pediatric Surgeons 07/2012; 17(3):104-6. DOI:10.4103/0971-9261.98120
  • [Show abstract] [Hide abstract]
    ABSTRACT: The [Cu(MIBI) 4]BF 4 complex was synthesized and different formulations for lyophilized kits that could be costeffectively used with different routines in nuclear medicine laboratories were investigated. In one preparation the kit components were kept similar to the CardioliteÒ, except that the SnCl 2.2H 2O concentration was increased to 0.150 mg. In a second formulation, component concentrations were reduced to 1/5 of the original value and the SnCl 2.2H 2O concentration was adjusted to 0.04 mg. These products were labeled with maximum activities of 55.5 GBq and 8.14 GBq, respectively, and have shown an average radiochemical purity of 95 %. Biodistribution of the products was assessed by dissection in mice and in rabbits, and did not show any statistical difference when compared to Cardiolite®. In the synthesis of [Cu(MIBI) 4]BF 4 a new procedure was introduced for the synthesis of N-(2-methyl-propenyl)-formamide, with the use of microwave radiation as heat source. This modification reduced the reaction time to 25 seconds, while maintaining a yield of 68%.
    Brazilian Archives of Biology and Technology 10/2005; 48(spe2). DOI:10.1590/S1516-89132005000700001 · 0.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Monoclonal antibodies (Mabs) have been u seful f or immunoscintigraphic applications in clinical diagnosis s ince they were introduced in the practice of nuclear medicine. The ior egf/r3 (Centis, Cuba) is a murine monoclonal antibody against epidermal growth factor receptor (EGF-R) and has been widely used in the radioimmunodiagnosis of t umors of epithelial origin. Labeled with 99 mTc, its main application in Nuclear Medicine is the follow up, detection and evaluation of tumor r ecurrences. The objective of this work is to describe the preparation o f a lyophilized formulation (kit) for radiolabeling the Mab ior egf/r3 with 99mTc for immunoscintigraphic applications. Radiolabeling efficiency, effects on immunoreactivity, image studies and stability of the formulation are reported. The study demonstrated that t he kit f ormulation can be labeled with 99mTc at high yields and can be used to visualize in vivo human tumors of epithelial origin by immunoscintigraphy studies.
    Brazilian Archives of Biology and Technology 10/2005; 48. DOI:10.1590/S1516-89132005000700004 · 0.55 Impact Factor
Show more